2Marchand M, Punt CJ, Aamdal S, et al. Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS 2: a clinical report. EurJ Cancer, 2003, 39(1): 70
2Mobkelob P H. Vaccines , coming of age after 200 years[J]. FEMS Microbiology Reviews, 2000, 24 (1): 9-20.
3Park J H, Lee S W. Hypertonicity induction of melanoma antigen, a tumor-associated antigen[J]. Mol Cells, 2002,13(2): 288-295.
4Melief C J, Toes R E, Medema J P, et al. Strategies for immunotherapy of cancer[J]. Adv Immunol, 2000, 75(1): 235-282.
5Coulie P G, Karanikas V, Lurquin C, et al. Cytolytic T-cell responses of cancer patients vaccinated with a MAGE antigen[J]. Immunol Rev, 2002,188(1): 33-42.
6Hao X, Shao Y, Ren X, et al. Induction of specific CTL by MAGE-3/CEA peptide-pulsed dendritic cells from HLA-A2/A24 (+) gastrointestinal cancer patients[J]. J Cancer Res Clin Oncol, 2002,128(9): 507-515.
7Coulie P G, Karanikas V, Colau D, et al. Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastro-intestinal carcinomas[J]. Clin Cancer Res, 2001,7(8): 2277-2286.
